57 related articles for article (PubMed ID: 12540841)
1. Promyelocytic leukemia protein sensitizes tumor necrosis factor alpha-induced apoptosis by inhibiting the NF-kappaB survival pathway.
Wu WS; Xu ZX; Hittelman WN; Salomoni P; Pandolfi PP; Chang KS
J Biol Chem; 2003 Apr; 278(14):12294-304. PubMed ID: 12540841
[TBL] [Abstract][Full Text] [Related]
2. The growth suppressor PML represses transcription by functionally and physically interacting with histone deacetylases.
Wu WS; Vallian S; Seto E; Yang WM; Edmondson D; Roth S; Chang KS
Mol Cell Biol; 2001 Apr; 21(7):2259-68. PubMed ID: 11259576
[TBL] [Abstract][Full Text] [Related]
3. PML colocalizes with and stabilizes the DNA damage response protein TopBP1.
Xu ZX; Timanova-Atanasova A; Zhao RX; Chang KS
Mol Cell Biol; 2003 Jun; 23(12):4247-56. PubMed ID: 12773567
[TBL] [Abstract][Full Text] [Related]
4. MADD, a splice variant of IG20, is indispensable for MAPK activation and protection against apoptosis upon tumor necrosis factor-alpha treatment.
Kurada BRVVSN; Li LC; Mulherkar N; Subramanian M; Prasad KV; Prabhakar BS
J Biol Chem; 2009 May; 284(20):13533-13541. PubMed ID: 19289468
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional cross talk between NF-kappaB and p53.
Webster GA; Perkins ND
Mol Cell Biol; 1999 May; 19(5):3485-95. PubMed ID: 10207072
[TBL] [Abstract][Full Text] [Related]
6. Caspase cleavage of iASPP potentiates its ability to inhibit p53 and NF-κB.
Hu Y; Ge W; Wang X; Sutendra G; Zhao K; Dedeić Z; Slee EA; Baer C; Lu X
Oncotarget; 2015 Dec; 6(40):42478-90. PubMed ID: 26646590
[TBL] [Abstract][Full Text] [Related]
7. The promyelocytic leukemia protein PML has a pro-apoptotic activity mediated through its RING domain.
Borden KL; CampbellDwyer EJ; Salvato MS
FEBS Lett; 1997 Nov; 418(1-2):30-4. PubMed ID: 9414089
[TBL] [Abstract][Full Text] [Related]
8. A novel role for the apoptosis inhibitor ARC in suppressing TNFα-induced regulated necrosis.
Kung G; Dai P; Deng L; Kitsis RN
Cell Death Differ; 2014 Apr; 21(4):634-44. PubMed ID: 24440909
[TBL] [Abstract][Full Text] [Related]
9. Celecoxib Suppresses NF-κB p65 (RelA) and TNFα Expression Signaling in Glioblastoma.
Ahsan H; Malik SI; Shah FA; El-Serehy HA; Ullah A; Shah ZA
J Clin Med; 2023 Oct; 12(20):. PubMed ID: 37892820
[TBL] [Abstract][Full Text] [Related]
10. A protective role for the human SMG-1 kinase against tumor necrosis factor-alpha-induced apoptosis.
Oliveira V; Romanow WJ; Geisen C; Otterness DM; Mercurio F; Wang HG; Dalton WS; Abraham RT
J Biol Chem; 2008 May; 283(19):13174-84. PubMed ID: 18326048
[TBL] [Abstract][Full Text] [Related]
11. Proto-oncogene PML enhances antigen presentation by MHC class I molecules in human lung cancer cells.
Chang SK; Park B; Shin J; Ahn JH; Kim IH; Ahn K
Mol Cells; 2002 Aug; 14(1):130-5. PubMed ID: 12243342
[TBL] [Abstract][Full Text] [Related]
12. Multipronged regulation of autophagy and apoptosis: emerging role of TRIM proteins.
Ahsan N; Shariq M; Surolia A; Raj R; Khan MF; Kumar P
Cell Mol Biol Lett; 2024 Jan; 29(1):13. PubMed ID: 38225560
[TBL] [Abstract][Full Text] [Related]
13. On the Prevalence and Roles of Proteins Undergoing Liquid-Liquid Phase Separation in the Biogenesis of PML-Bodies.
Silonov SA; Mokin YI; Nedelyaev EM; Smirnov EY; Kuznetsova IM; Turoverov KK; Uversky VN; Fonin AV
Biomolecules; 2023 Dec; 13(12):. PubMed ID: 38136675
[TBL] [Abstract][Full Text] [Related]
14. LDL Affects the Immunomodulatory Response of Endothelial Cells by Modulation of the Promyelocytic Leukemia Protein (PML) Expression via PKC.
Roos K; Berkholz J
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108469
[TBL] [Abstract][Full Text] [Related]
15. Promyelocytic leukemia protein targets MK2 to promote cytotoxicity.
Chen IT; Chen HC; Lo YH; Lai PY; Hsieh FY; Wu YH; Shih HM; Lai MZ
EMBO Rep; 2021 Dec; 22(12):e52254. PubMed ID: 34633746
[TBL] [Abstract][Full Text] [Related]
16. TRIMming Type I Interferon-Mediated Innate Immune Response in Antiviral and Antitumor Defense.
Wang L; Ning S
Viruses; 2021 Feb; 13(2):. PubMed ID: 33670221
[TBL] [Abstract][Full Text] [Related]
17. To TRIM the Immunity: From Innate to Adaptive Immunity.
Yang W; Gu Z; Zhang H; Hu H
Front Immunol; 2020; 11():02157. PubMed ID: 33117334
[TBL] [Abstract][Full Text] [Related]
18. Revisiting promyelocytic leukemia protein targeting by human cytomegalovirus immediate-early protein 1.
Paulus C; Harwardt T; Walter B; Marxreiter A; Zenger M; Reuschel E; Nevels MM
PLoS Pathog; 2020 May; 16(5):e1008537. PubMed ID: 32365141
[TBL] [Abstract][Full Text] [Related]
19. TRIM22 inhibits endometrial cancer progression through the NOD2/NF‑κB signaling pathway and confers a favorable prognosis.
Zhang L; Zhang B; Wei M; Xu Z; Kong W; Deng K; Xu X; Zhang L; Ζhao X; Yan L
Int J Oncol; 2020 May; 56(5):1225-1239. PubMed ID: 32319602
[TBL] [Abstract][Full Text] [Related]
20. Enhanced O-linked Glcnacylation in Crohn's disease promotes intestinal inflammation.
Sun QH; Wang YS; Liu G; Zhou HL; Jian YP; Liu MD; Zhang D; Ding Q; Zhao RX; Chen JF; Li YN; Liang J; Li YL; Quan CS; Xu ZX
EBioMedicine; 2020 Mar; 53():102693. PubMed ID: 32114385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
